Table 6.
Discharge medications
| STEMI (n=514) | UA/NSTEMI (n=520) | |
|---|---|---|
| Antiplatelets, n (%) | ||
| ASA | 508 (98.8) | 509 (97.9) |
| Clopidogrel | 478 (93.0) | 419 (80.6) |
| Combined ASA/clopidogrel use | ||
| ASA only | 36 (7.0) | 97 (18.7) |
| Clopidogrel only | 6 (1.2) | 7 (1.3) |
| ASA + Clopidogrel | 472 (91.8) | 412 (79.2) |
| Neither | 0 (0.0) | 4 (0.8) |
| Ticlopidine | 23 (4.5) | 6 (1.2) |
| Other antiplatelet | 3 (0.6) | 1 (0.2) |
| By stent placement during PCI | ||
| YES | 434 (84.4) | 276 (53.1) |
| ASA | 428 (98.6) | 273 (98.9) |
| Clopidogrel | 415 (95.6) | 270 (97.8) |
| Ticlopidine | 18 (4.1) | 5 (1.8) |
| Other antiplatelet | 3 (0.7) | 0 (0.0) |
| NO | 80 (15.6) | 244 (46.9) |
| ASA | 80 (100) | 236 (96.7) |
| Clopidogrel | 63 (78.8) | 149 (61.1) |
| Ticlopidine | 5 (6.3) | 1 (0.4) |
| Other antiplatelet | 0 (0.0) | 1 (0.4) |
| Anticoagulants (Acenocoumarol/Warfarin) | 2 (0.4) | 3 (0.6) |
| Other CV therapies | ||
| Beta blockers | 466 (90.7) | 466 (89.6) |
| ACE/ARB inhibitors | 439 (85.4) | 413 (79.4) |
| Lipid lowering drugs | ||
| Total | 463 (90.1) | 460 (88.5) |
| Atorvastatin | 337 (65.6) | 307 (59.0) |
| Pravastatin | 1 (0.2) | 2 (0.4) |
| Rosuvastatin | 122 (23.7) | 145 (27.9) |
| Simvastatin | 1 (0.2) | 2 (0.4) |
| Other | 5 (1.0) | 6 (1.2) |
| Diuretics | 48 (9.3) | 42 (8.1) |
| Aldosterone inhibitors | 41 (8.0) | 14 (2.7) |
| Ca-channel blocker | 26 (5.1) | 60 (11.5) |
| Non-CV therapies | ||
| PPIs | ||
| Total | 175 (34.0) | 155 (29.8) |
| Omeprazole | 26 (5.1) | 8 (1.5) |
| Pantoprazole | 99 (19.3) | 106 (20.4) |
| Rabeprazole | 2 (0.4) | 1 (0.2) |
| Esomeprazole | 2 (0.4) | 9 (1.7) |
| Lansoprazole | 47 (9.1) | 31 (6.0) |
| H2-receptor antagonist | 78 (15.2) | 66 (12.7) |
| NSAIDs (traditional and coxibs) | 1 (0.2) | 2 (0.4) |
ACE - angiotensin-converting-enzyme inhibitor; ARB - angiotensin receptor blockers; ASA - acetylsalicylic acid; Ca - calcium; CV - cardiovascular; NSAIDs - non-steroidal anti-inflammatory drugs; NSTEMI - non-ST-segment elevation myocardial infarction; PCI - percutaneous coronary intervention; PPIs - proton pump inhibitors; STEMI – Stsegment elevation myocardial infarction; UA - unstable angina